Related Experiment Video
Updated: Jun 28, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Growth stimulation leads to cellular senescence when the cell cycle is blocked
Zoya N Demidenko1, Mikhail V Blagosklonny
1Oncotarget, Albany, New York, USA.
Abstract:
We tested a hypothesis that activation of growth-promoting pathways is required for cellular senescence. In the presence of serum, induction of p21 caused senescence, characterized by beta-Galactosidase staining, cell hypertrophy, increased levels of cyclin D1 and active TOR (target of rapamycin, also known as mTOR). Serum starvation and rapamycin inhibited TOR and prevented the expression of some senescent markers, despite high levels of p21 and cell cycle arrest. In the presence of serum, p21-arrested cells irreversibly lost proliferative potential. In contrast, when cells were arrested by p21 in the absence of serum, they retained the capacity to resume proliferation upon termination of p21 induction. In normal human cells such as WI38 fibroblasts and retinal pigment epithelial (RPE) cells, serum starvation caused quiescence, which was associated with low levels of cyclin D1, inactive TOR and slim-cell morphology. In contrast, cellular senescence with high levels of TOR activity was induced by doxorubicin (DOX), a DNA damaging agent, in the presence of serum. Inhibition of TOR partially prevented senescent phenotype caused by DOX. Thus growth stimulation coupled with cell cycle arrest leads to senescence, whereas quiescence (a condition with inactive TOR) prevents senescence.
Insights
Cellular senescence requires growth signaling pathways like mTOR activation. Inhibiting mTOR can prevent senescence, while quiescence, a state of low mTOR activity, protects cells from becoming senescent.
Area of Science:
- Cell Biology
- Molecular Biology
- Aging Research
Background:
- Cellular senescence is a state of irreversible growth arrest.
- The role of growth-promoting pathways in senescence induction remains unclear.
- Understanding senescence is crucial for aging and cancer research.
Purpose of the Study:
- To investigate the requirement of growth-promoting pathways for cellular senescence.
- To determine the role of the target of rapamycin (TOR) pathway in senescence.
- To differentiate between senescence and quiescence.
Main Methods:
- Induction of p21 to cause cell cycle arrest in the presence and absence of serum.
- Treatment with rapamycin to inhibit TOR activity.
- Assessment of senescent markers: beta-Galactosidase staining, cell hypertrophy, cyclin D1 levels, and TOR activity.
- Use of doxorubicin (DOX) to induce senescence in normal human cells (WI38 fibroblasts, RPE cells).
Main Results:
- In serum, p21 induction caused senescence with high TOR activity, cyclin D1, and hypertrophy.
- Serum starvation or rapamycin inhibited TOR, preventing some senescent markers despite p21-induced arrest.
- p21-arrested cells in serum lost proliferative potential irreversibly; cells arrested without serum retained it.
- Quiescence (low TOR) in WI38 and RPE cells was characterized by slim morphology and low cyclin D1.
- DOX-induced senescence in serum involved high TOR activity; TOR inhibition partially prevented this phenotype.
Conclusions:
- Growth stimulation coupled with cell cycle arrest is necessary for cellular senescence.
- The target of rapamycin (TOR) pathway activation is a key component of the senescent phenotype.
- Quiescence, characterized by inactive TOR, prevents senescence and preserves proliferative capacity.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Cells Coordinate Growth and Proliferation
Cells Coordinate Growth and Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Mitogens and the Cell Cycle

